ON THIS PAGESymptomsComplicationsWhy Fulminant Colitis OccursWhat to Do During a Severe UC FlareAfter a Fulminant UC EpisodeFor some people with ulcerative colitis (UC), the symptoms are mild. But for ...

Both Crohn's disease and ulcerative colitis are forms of inflammatory bowel disease (IBD) and share similar symptoms. Crohn's disease can cause inflammation anywhere from your mouth to your anus, ...

A novel vaccination approach developed by Vanderbilt Health researchers cleared the harmful gut bacterium Clostridioides difficile (C. diff) in an animal model of infection. An experimental vaccine ...

POO transplants could rejuvenate the ovaries to boost fertility, researchers say. The treatment – which involves placing a ...

For more than a century, the human appendix has been written off as a biological relic, a shrunken leftover from plant-eating ancestors that serves no real purpose. That view is now outdated. A ...

The Department of Defense is tapping a research team led by Mount Sinai to study a novel treatment for ulcerative colitis, an enemy within that disproportionately impacts individuals in the military.

Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.

Dear Dr. Roach: About one year ago, I had Clostridioides difficile (C. diff) that was treated with 125 mg of vancomycin for about four weeks. I had none of the usual risk factors, and the cause was ...

Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary ...

Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed ...

Dentists wrote more than 2.3 million prescriptions last year for an antibiotic called clindamycin, whose label has carried a ...